George has attached a Precision BioLogic Inc. news release describing the outcomes of factor IX assay studies conducted with Sobi. The data were published in poster format at 11th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD). Thanks to Elaine Benoit, Precision BioLogic for the heads-up, and to Ali Sadeghi-Khomami PhD for his efforts in helping design and execute the study. Attached is a copy of the EAHAD abstract.
Willemze A, Sadeghi-Khomami A, Sörskog L,Wikén M, Lethagen S. Assessment of clotting activity of recombinant FIX Fc fusion protein in European hemophilia treatment centers.
No comments here.